Fudem G M, Walton R L
Department of Plastic and Reconstructive Surgery, University of Massachusetts Medical Center, Worcester 01655.
J Reconstr Microsurg. 1989 Jul;5(3):231-4. doi: 10.1055/s-2007-1006872.
Nonsurgical thrombolysis using tissue plasminogen activator (t-PA) in conjunction with intravenous heparin infusion was successfully used to salvage a free flap with acutely decreased arterial inflow thought to be due to anastomotic thrombosis. Intravenous infusion (12 mg/hr) of t-PA was stopped after 15 min of therapy when spontaneous bleeding was noted at the groin flap donor site. Concomitant treatment with intravenous heparin resulted in rapid improvement of flap perfusion and ultimately complete survival without surgical intervention. This report suggests that in selected cases, target-specific anticoagulant therapy may be beneficial in salvaging microvascular reconstructions complicated by thrombosis. Further experience is warranted to define more clearly the role, the risks, and the extended benefits of this new mode of nonsurgical therapy.
使用组织型纤溶酶原激活剂(t-PA)联合静脉输注肝素进行非手术溶栓,成功挽救了因吻合口血栓形成导致动脉血流急性减少的游离皮瓣。治疗15分钟后,当腹股沟皮瓣供区出现自发性出血时,停止了t-PA的静脉输注(12毫克/小时)。静脉肝素的联合治疗使皮瓣灌注迅速改善,最终无需手术干预皮瓣完全存活。本报告表明,在某些特定情况下,靶向特异性抗凝治疗可能有助于挽救并发血栓形成的微血管重建。需要进一步的经验来更明确地界定这种新的非手术治疗模式的作用、风险和广泛益处。